English
Kopran Q3 Results
- BSE: 524280
- NSE: KOPRAN
- ISIN: INE082A01010
- Sector: Biotechnology & Drugs
BSE
151.20
-8.00 (-5.03%)
-8.00 (-5.03%)Volume50.59 K
Updated: Wed 12 Nov, 2025 | 15:58:10
NSE
151.48-7.63 (-4.80%)
-7.63 (-4.80%)Volume1.05 M
Updated: Wed 12 Nov, 2025 | 15:29:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Kopran Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 150.40 | 140.68 | 6.91% | 138.60 | 8.51% |
| Depreciation/ Amortization | 4.00 | 3.85 | 3.68% | 3.27 | 22.39% |
| Operating Income | 15.84 | 10.88 | 45.56% | 20.32 | -22.02% |
| Net Income | 10.40 | 7.38 | 40.78% | 15.79 | -34.18% |
| Other Operating Expenses Total | 25.30 | 24.64 | 2.68% | 21.97 | 15.18% |
| Net Income Before Taxes | 13.86 | 9.64 | 43.69% | 20.51 | -32.42% |
| Total Revenue | 166.24 | 151.56 | 9.69% | 158.92 | 4.61% |
| Selling/ General/ Admin Expenses Total | 15.40 | 14.53 | 5.97% | 13.74 | 12.02% |
| Diluted Normalized EPS | 2.15 | 1.53 | 40.52% | 3.27 | -34.25% |